United Therapeutics CEO Martine Rothblatt reports sale of 9,500 common shares worth $5.04 million - UTHR News | RalliesUnited Therapeutics CEO Martine Rothblatt reports sale of 9,500 common shares worth $5.04 million
U
UTHR• United Therapeutics CEO reports option exercise and share sale
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $135.42 on July 24, 2026.
- A related trust sold 9,500 shares the same day at weighted-average prices around $528.72 to $535.03.
- The trust reported 324,443 shares beneficially owned following the transactions.
NEE
•
